Therefore, we investigated AKT, p-AKT, SGK3, and p-SGK3 expression after INPP4B overexpression in order to reveal the AKT and/or SGK3 pathways as potential INPP4B signaling mechanisms in etoposide-resistant RB cells. The gene discussed is INPP4B; the disease is retinoblastoma.